HRB Clinical Research Facility, Galway
Áis Taighde Chliniciúil HRB, Gaillimh
A team at NUI Galway are conducting a clinical trial study on bipolar disorder.
Nature of the study
SCOPE-BD is a randomised controlled trial investigating if IV Scopolamine (Hyoscine) has a rapid treatment effect for individuals with Bipolar Disorder experiencing a depressive episode.
Participants
In order to take part you need to have a diagnosis of bipolar disorder, be at least 18 years of age and are currently experiencing a depressive episode.
More Details
If you or your patient would like to participate or receive more information, please email:
• Ruán Kane
• Cerena Miravalles
• (PI) Dr. Brian Hallahan
Or call/text the study team directly on: 086-0081175 (Ruán/Cerena)
